Population
41 African-American subjects who are first-degree relatives of African-American patients with type 2 diabetes.
Design
Cross-sectional
Authors
Loading...
Adiponectin may mark preclinical insulin resistance in at-risk African-Americans; hypothesis-generating and requires longitudinal confirmation before clinical use.
Decreased plasma adiponectin and insulin resistance coexist in genetically prone African-American individuals before the development of impaired glucose tolerance and type 2 diabetes.
Osei et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: